Literature DB >> 4469035

Verapamil in the treatment of paroxysmal supraventricular tachycardia.

D M Krikler, R A Spurrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4469035      PMCID： PMC2495777          DOI： 10.1136/pgmj.50.585.447

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  23 in total

1.  [CLINICAL STUDY OF THE EFFECT OF ISOPTIN AND ISOPTIN S IN PATIENTS WITH CORONARY INSUFFICIENCY].

Authors:  B TSCHIRDEWAHN; H KLEPZIG
Journal:  Dtsch Med Wochenschr       Date:  1963-08-30       Impact factor: 0.628

2.  [TREATMENT OF CORONARY CIRCULATORY DISORDERS WITH ISOPTIN IN GENERAL PRACTICE].

Authors:  P HOFFMANN
Journal:  Med Klin       Date:  1964-08-28

3.  Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle.

Authors:  W G Nayler; J Szeto
Journal:  Cardiovasc Res       Date:  1972-03       Impact factor: 10.787

4.  Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.

Authors:  R A Spurrell; D M Krikler; E Sowton
Journal:  Br Heart J       Date:  1974-03

5.  Action of verapamil on sinus node, atrioventricular, and intraventricular conduction.

Authors:  M H Husaini; J Kvasnicka; L Ryèn; S Holmberg
Journal:  Br Heart J       Date:  1973-07

6.  Two or more intra AV nodal pathways in association with either a James or Kent extranodal bypass in 3 patients with paroxysmal supraventricular tachycardia.

Authors:  R A Spurrell; D Krikler; E Sowton
Journal:  Br Heart J       Date:  1973-02

7.  [Clinical study of a new antiarrhythmic drug].

Authors:  A Abaza; C Bodinier; C Aziza; J C Garnier
Journal:  Coeur Med Interne       Date:  1972 Oct-Dec

8.  Verapamil in life-threatening tachyarrhythmias.

Authors:  M S Gotsman; B S Lewis; A Bakst; A S Mitha
Journal:  S Afr Med J       Date:  1972-12-23

9.  Verapamil in cardiac arrhythmias.

Authors:  H Sacks; B M Kennelly
Journal:  Br Med J       Date:  1972-06-17

10.  A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function.

Authors:  B N Singh
Journal:  Cardiovasc Res       Date:  1972-03       Impact factor: 10.787
View more
  38 in total

Review 1.  Calcium-channel blockers and anaesthesia.

Authors:  P G Durand; J J Lehot; P Foëx
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

2.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

Review 3.  Calcium antagonists and their mode of action: an historical overview.

Authors:  W G Nayler; J S Dillon
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 4.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

5.  Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study.

Authors:  E Rowland; T Evans; D Krikler
Journal:  Br Heart J       Date:  1979-08

6.  Verapamil pharmacokinetics and apparent hepatic and renal blood flow.

Authors:  P A Meredith; H L Elliott; F Pasanisi; A W Kelman; D J Sumner; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

7.  Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity.

Authors:  R J Sung; W A Shapiro; E N Shen; F Morady; J Davis
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

8.  Assessment of 'once daily' verapamil for the treatment of hypertension using ambulatory, intra-arterial blood pressure recording.

Authors:  M Caruana; M Heber; G Brigden; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.

Authors:  N S Khurmi; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 10.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.